ClinicalTrials.gg
CompletedNCT05054270Updated Jul 30, 2024

Efficacy of Lung Ultrasound in Monitoring Fluid Resuscitation in Chest Trauma Patients

An observational study in Contusions Pulmonary, Lung Injury and Chest Trauma, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-30.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Efficacy of Lung ultrasound in monitoring fluid resuscitation in chest trauma patients with lung contusions

Read the detailed description

Trauma is a public health problem, associated to high morbidity and mortality, In Egypt the mortality from road traffic crashes is about 12000 victims per year.

  • Chest trauma represents from 10% to 15% of the total number of traumas worldwide.

According to ATLS protocol , early diagnosis and management of Chest trauma are essential. *Pulmonary contusion is found in 30-75% of cases of chest injury.

  • point of care Ultrasound (POCUS) is Now a corner stone in Emergency management it can predict lung contusions within the first 72 hours after trauma.
  • Recently, LUS Play a major role in assessment of the volume status in Trauma patients.
  • B-lines score (BLS) has been validated as a lung ultrasound quantification of pulmonary congestion.The sum of all B-lines yields a score, B-lines score (BLS), which assess the degree of lung contusion. So that LUS may provide a valuable safety threshold to conduct fluid therapy.
02

Conditions studied

  • Contusions Pulmonary
  • Lung Injury
  • Chest Trauma
  • Fluid Overload Pulmonary Edema
03

In context

Lung Injury

114 studies on the registry are indexed under Lung Injury; 33 are open to participants now.

This study's enrollment of 100 is close to the median of 100 across 35 observational studies indexed under Lung Injury.

Browse Lung Injury studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

This is an observational study that will be conducted on patients admitted with chest trauma in Assuit or Alexandria Main University Hospitals after obtaining their or their next of kin consent to participate in the study without affecting their course of treatment according to permission obtained from ethical committee of faculty of medicine in Assiut and Alexandria universities.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age > 18 years.
  • chest trauma patients either with or without other injuries.
  • Any patient with either blunt or penetrating chest trauma.

Exclusion criteria

Exclusion Criteria:

    • Patients in cardiac arrest.
  • Patient refusal to participate
  • Pregnant females.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (actual)
Patient registry
No

Interventions

  • OtherChest examination with Ultrasound device

    Chest examination with Ultrasound device

06

What researchers measure

Primary outcomes

  1. Number of patients with lung contusion

    Pulmonary edema will be detected by B_lines trauma patients with lung contusions

    Time frame: Upto 24 hours after trauma

Secondary outcomes

  1. Clinical correlation between Type & volume of Fluid & occurance of pulmonary edema. Correlation between severity of pulmonary lung contusion & The final disposition of the patients whatever (OR _another department _death….. etc) upto 24hr.

    Follow up on degree of contusions after fluid resuscitation

    Time frame: For first 24 hours after trauma

07

Study locations

1 site
  • Faculty of medicine Assiut University
    Assiut, Egypt
08

References and documents

Publications

  • Ullman EA, Donley LP, Brady WJ. Pulmonary trauma emergency department evaluation and management. Emerg Med Clin North Am. 2003 May;21(2):291-313. doi: 10.1016/s0733-8627(03)00016-6. PubMed 12793615 ↗
  • Miller DL, Mansour KA. Blunt traumatic lung injuries. Thorac Surg Clin. 2007 Feb;17(1):57-61, vi. doi: 10.1016/j.thorsurg.2007.03.017. PubMed 17650697 ↗
  • Cohn SM. Pulmonary contusion: review of the clinical entity. J Trauma. 1997 May;42(5):973-9. doi: 10.1097/00005373-199705000-00033. PubMed 9191684 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05054270
Lead sponsor
Assiut University
Responsible party
Aya Yassien Mahmoud Ahmed (Emergency medicine resident physician, Assiut University) — Principal investigator
First posted
Sep 23, 2021
Start date
Jul 1, 2021
Primary completion
Jun 1, 2022
Completion
Jun 1, 2023
Last update
Jul 30, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion